{"id":"W4220881379","doi":"10.1016/j.cllc.2022.03.002","title":"Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management","year":2022,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Cilag; National Cancer Institute; Chugai Pharmaceutical; EMD Serono; Samsung; Genentech; Ipsen; Ono Pharmaceutical; Servier; Les Laboratories Pierre Fabre; Taiho Pharmaceutical; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Yuhan; Merck KGaA; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Nausea; Vomiting; Hypoalbuminemia; Internal medicine; Pleural effusion; Adverse effect; Discontinuation; Gastroenterology; Tolerability; Creatinine; Diarrhea","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003590404,0.0001471021,0.0006154499,0.0002607942,0.0002213123,0.0007280854,0.0003447605,0.000466385,0.0007129765],"category_scores_gemma":[0.00646495,0.00008359858,0.0005577634,0.0004271943,0.0001720881,0.0005720551,0.0002385485,0.0008828494,0.0001630503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004837239,"about_ca_system_score_gemma":0.0007787673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002870976,"about_ca_topic_score_gemma":0.0006801161,"domain_scores_codex":[0.9988542,0.000449203,0.0002031519,0.0001052516,0.0003212143,0.00006703335],"domain_scores_gemma":[0.9956574,0.001484324,0.002011418,0.00009522362,0.0004999024,0.0002515996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01381464,0.0003972758,0.6041932,0.001210804,0.0006809717,0.0005869826,0.0002210595,0.002152367,0.004683032,0.000389344,0.006842162,0.3648282],"study_design_scores_gemma":[0.003172332,0.01556709,0.9430689,0.001317477,0.001022227,0.003532263,0.0003653614,0.005271442,0.003698884,0.001193784,0.02173015,0.00006009598],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9342721,0.04649995,0.001725767,0.009559917,0.0001933369,0.0002261879,0.001418342,0.00006881685,0.006035715],"genre_scores_gemma":[0.989346,0.005025925,0.001178674,0.002329233,0.0002597338,0.000100573,0.001355141,0.000009172489,0.0003957364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003590404,"threshold_uncertainty_score":0.01898813,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02745209117655718,"score_gpt":0.4104270657523426,"score_spread":0.3829749745757854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}